Signalling systems in lung vascular disease

N. Morrell (Cambridge, United Kingdom)

Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Number: 5

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Morrell (Cambridge, United Kingdom). Signalling systems in lung vascular disease. Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Signalling mechanisms that regulate lung inflammation in humans
Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD
Year: 2004

SMAD3 regulation contributes to lung vascular remodeling in pulmonary arterial hypertension
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015



Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016



The role of vascular endothelial growth factor D in diagnosis of polycystic lung diseases
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013

A potential role for endothelial adhesion molecules and cytokines in chemotherapy-induced lung fibrosis
Source: International Congress 2014 – Cell biology 2014
Year: 2014


Role of TNF-a in ventilator-induced lung injury in the developing murine lung
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013

Differential VEGF signalling in the lung
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013


Cellular mechanisms of paediatric lung disease
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease
Source: Eur Respir J 2005; 26: 762-763
Year: 2005


Crosstalk between lung fibroblasts and T-lymphocytes: Implications for anti-viral responses in chronic lung disease
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013

Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling?
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Potential role of SPARC, a downstream mediator of TGF-b in chronic airways disease
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015

The effects of tobramycin on pulmonary fibroblast function
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Endotelialny dysfunction at patients with COPD and coronary heart disease
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Crosstalk between endothelin-1 and BMPR2 signaling contributes to smooth muscle cell hyperplasia
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Roles of circulating and resident myeloid cell subpopulations in bronchopulmonary remodeling and pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013